Christopher Richard Anzalone, Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 200,000 shares at $58.16 ($11.6M) on 2020-10-23, disclosed to the SEC on 2020-10-23.
Open-market sale of $11.6M ARWR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.16 | 87,728 | $5.1M | 43.8% |
| 2 | $58.16 | 87,728 | $5.1M | 43.8% |
| 3 | $58.57 | 12,272 | $719K | 6.2% |
| 4 | $58.57 | 12,272 | $719K | 6.2% |
| Total | $58.21 avg | 200,000 | $11.6M | 100% |
| Filing → |
| ARWR | SELL | 2025-12-23 | $3.5M | — | Filing → |
| ARWR | SELL | 2025-12-19 | $10.9M | — | Filing → |
| ARWR | SELL | 2025-12-16 | $24.6M | — | Filing → |